Key Statistics for 2176
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (JPY) (ttm)
|Est. EPS (JPY) (03/2014)
|Est. PEG Ratio
|Market Cap (M JPY)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (JPY)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 2176
- Net Income (M/JPY)
Ina Research Inc. provide Clinical and Non-Clinical trial services mainly for pharmaceutical companies. The company examines drug safety and efficacy with utilizing laboratory animals. Ina Research also provides health food efficacy studies.
More Company Profile & Key Executives for 2176
|Hiroshi NakagawaChairman||Kenji NakagawaPresident|
|Kimio YonedaDirector||Toshiyasu HonboDirector|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.